Is the use of low molecular weight heparin a rational choice during pregnancy in patients with a mechanical heart valve: A report of three cases


GÜNER A., BAYAM E., Kalkan S., Gündüz S., Özkan M.

Turk Kardiyoloji Dernegi Arsivi, cilt.47, sa.1, ss.63-68, 2019 (Scopus, TRDizin)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 47 Sayı: 1
  • Basım Tarihi: 2019
  • Doi Numarası: 10.5543/tkda.2018.83364
  • Dergi Adı: Turk Kardiyoloji Dernegi Arsivi
  • Derginin Tarandığı İndeksler: Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.63-68
  • Anahtar Kelimeler: Low molecular weight heparin, mechanical heart valve, prosthetic valve thrombosis
  • Sağlık Bilimleri Üniversitesi Adresli: Evet

Özet

Pregnancy is associated with an increased risk of valve thrombosis in patients with a mechanical prosthetic heart valve. The administration of low molecular weight heparin (LMWH) with regular anti-factor Xa assessment is a recommended treatment modality for these patients. Presently described are 3 cases of therapy with LMWH during pregnancy. Despite frequent anti-factor Xa monitoring, not surprisingly, all of them developed prosthetic valve thrombosis.